Literature DB >> 30990942

Unidirectional Presentation of Membrane Proteins in Nanoparticle-Supported Liposomes.

Wen Chen1, Yongfei Cai2, Qingshan Fu1, Bing Chen2, Junling Guo3, James J Chou1.   

Abstract

Presentation of membrane proteins to host immune systems has been a challenging problem owing to complexity arising from the poor in vivo stability of the membrane-mimetic media often used for solubilizing the membrane proteins. The use of functionalized, biocompatible nanoparticles as substrates is shown to guide the formation of proteoliposomes, which can present many copies of membrane proteins in a unidirectional manner. The approach was demonstrated to present the membrane-proximal region of the HIV-1 envelope glycoprotein. These nanoparticle-supported liposomes are broadly applicable as membrane antigen vehicles for inducing host immune responses.
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  HIV-1 MPER; membrane antigen presentation; nanoparticles; proteoliposome formation; unidirectionality

Year:  2019        PMID: 30990942      PMCID: PMC6660371          DOI: 10.1002/anie.201903093

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  28 in total

1.  Use of proteoliposomes to generate phage antibodies against native AMPA receptor.

Authors:  L K Jespersen; A Kuusinen; A Orellana; K Keinänen; J Engberg
Journal:  Eur J Biochem       Date:  2000-03

2.  Reconstitution of membrane proteins into liposomes.

Authors:  Jean-Louis Rigaud; Daniel Lévy
Journal:  Methods Enzymol       Date:  2003       Impact factor: 1.600

3.  The membrane-proximal external region of HIV-1 gp41: a vaccine target worth exploring.

Authors:  Michael B Zwick
Journal:  AIDS       Date:  2005-11-04       Impact factor: 4.177

4.  A fusion-intermediate state of HIV-1 gp41 targeted by broadly neutralizing antibodies.

Authors:  Gary Frey; Hanqin Peng; Sophia Rits-Volloch; Marco Morelli; Yifan Cheng; Bing Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-05       Impact factor: 11.205

5.  Characterization of a trimeric MPER containing HIV-1 gp41 antigen.

Authors:  Andreas Hinz; Guy Schoehn; Heribert Quendler; David Lutje Hulsik; Gabi Stiegler; Hermann Katinger; Michael S Seaman; David Montefiori; Winfried Weissenhorn
Journal:  Virology       Date:  2009-06-18       Impact factor: 3.616

6.  A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1.

Authors:  G Stiegler; R Kunert; M Purtscher; S Wolbank; R Voglauer; F Steindl; H Katinger
Journal:  AIDS Res Hum Retroviruses       Date:  2001-12-10       Impact factor: 2.205

7.  High-affinity adaptors for switchable recognition of histidine-tagged proteins.

Authors:  Suman Lata; Annett Reichel; Roland Brock; Robert Tampé; Jacob Piehler
Journal:  J Am Chem Soc       Date:  2005-07-27       Impact factor: 15.419

8.  Direct solubilization of heterologously expressed membrane proteins by incorporation into nanoscale lipid bilayers.

Authors:  Natanya R Civjan; Timothy H Bayburt; Mary A Schuler; Stephen G Sligar
Journal:  Biotechniques       Date:  2003-09       Impact factor: 1.993

Review 9.  Membrane protein assembly into Nanodiscs.

Authors:  Timothy H Bayburt; Stephen G Sligar
Journal:  FEBS Lett       Date:  2009-10-16       Impact factor: 4.124

Review 10.  Virus-like particles: passport to immune recognition.

Authors:  Elizabeth V L Grgacic; David A Anderson
Journal:  Methods       Date:  2006-09       Impact factor: 3.608

View more
  2 in total

1.  Alloyed nanostructures integrated metal-phenolic nanoplatform for synergistic wound disinfection and revascularization.

Authors:  Yi Xie; Shengqiu Chen; Xu Peng; Xiaoling Wang; Zhiwei Wei; Joseph J Richardson; Kang Liang; Hirotaka Ejima; Junling Guo; Changsheng Zhao
Journal:  Bioact Mater       Date:  2022-03-19

2.  Loureirin B activates GLP-1R and promotes insulin secretion in Ins-1 cells.

Authors:  Yanting Ding; Sijing Xia; Han Zhang; Qin Chen; Bing Niu
Journal:  J Cell Mol Med       Date:  2020-12-10       Impact factor: 5.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.